120 related articles for article (PubMed ID: 3481555)
1. Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model.
Dixit V; Chang TM
Biomater Artif Cells Artif Organs; 1987; 15(3):559-73. PubMed ID: 3481555
[TBL] [Abstract][Full Text] [Related]
2. Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems.
Dixit V; Chang TM
ASAIO Trans; 1990; 36(1):21-7. PubMed ID: 2306387
[TBL] [Abstract][Full Text] [Related]
3. Effects of polylactic acid microcapsules containing prostaglandin E2 on the survival rates of grade II coma galactosamine induced fulminant hepatic failure rats.
Zhou MX; Chang TM
Biomater Artif Cells Artif Organs; 1987; 15(3):549-58. PubMed ID: 3481554
[TBL] [Abstract][Full Text] [Related]
4. Preliminary report on effects of prostaglandin E2 on brain edema in fulminant hepatic failure rats.
Dixit V; Chang TM
Int J Artif Organs; 1985 Jan; 8(1):55-6. PubMed ID: 3855843
[No Abstract] [Full Text] [Related]
5. TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure.
Yamamoto S; Nguyen JH
J Surg Res; 2006 Aug; 134(2):307-14. PubMed ID: 16488444
[TBL] [Abstract][Full Text] [Related]
6. Middle molecules in the serum, brain, liver and urine of galactosamine-induced fulminant hepatic failure rats.
Shu CD; Chang TM
Int J Artif Organs; 1983 Sep; 6(5):273-7. PubMed ID: 6642726
[TBL] [Abstract][Full Text] [Related]
7. Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema.
Ede RJ; Gove CD; Hughes RD; Marshall W; Williams R
Clin Sci (Lond); 1987 Mar; 72(3):365-71. PubMed ID: 3028700
[TBL] [Abstract][Full Text] [Related]
8. Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier.
Traber PG; Dal Canto M; Ganger DR; Blei AT
Hepatology; 1987; 7(6):1272-7. PubMed ID: 3679092
[TBL] [Abstract][Full Text] [Related]
9. Effects of prostaglandin E2 on the survival time of fulminant hepatic failure rats.
Dixit V; Chang TM
Int J Artif Organs; 1982 Nov; 5(6):388. PubMed ID: 7160937
[No Abstract] [Full Text] [Related]
10. An animal model of fulminant hepatic failure in the rat.
Watanabe A; Higashi T; Nagashima H
Acta Med Okayama; 1979 Dec; 33(6):443-50. PubMed ID: 161469
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid receptor, LPA
Masago K; Kihara Y; Yanagida K; Hamano F; Nakagawa S; Niwa M; Shimizu T
Biochem Biophys Res Commun; 2018 Jul; 501(4):1048-1054. PubMed ID: 29778535
[TBL] [Abstract][Full Text] [Related]
12. [Study on variation of plasma gamma-aminobutyric acid concentration in rat model of hepatic encephalopathy due to fulminant hepatic failure].
He X; Luan Y
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):45-8. PubMed ID: 1398623
[TBL] [Abstract][Full Text] [Related]
13. The anti-proliferative effect of plasma from rats with acute fulminant hepatic failure.
Anilkumar T; Ryan CJ; Aslam M; Poulsom R; Alison M
Scand J Gastroenterol; 1997 Nov; 32(11):1152-61. PubMed ID: 9399398
[TBL] [Abstract][Full Text] [Related]
14. The effects of homologous cross-circulation and in situ liver perfusion on fulminant hepatic failure rats.
Mohsini K; Lister C; Chang TM
Artif Organs; 1980 Aug; 4(3):171-5. PubMed ID: 7417030
[TBL] [Abstract][Full Text] [Related]
15. Regional cerebral edema and chloride space in galactosamine-induced liver failure in rats.
Gove CD; Hughes RD; Ede RJ; Williams R
Hepatology; 1997 Feb; 25(2):295-301. PubMed ID: 9021937
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice.
Nguyen JH; Yamamoto S; Steers J; Sevlever D; Lin W; Shimojima N; Castanedes-Casey M; Genco P; Golde T; Richelson E; Dickson D; McKinney M; Eckman CB
J Hepatol; 2006 Jun; 44(6):1105-14. PubMed ID: 16458990
[TBL] [Abstract][Full Text] [Related]
17. Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2.
Schmidley JW; Dadson J; Iyer RS; Salomon RG
Prostaglandins Leukot Essent Fatty Acids; 1992 Oct; 47(2):105-10. PubMed ID: 1461920
[TBL] [Abstract][Full Text] [Related]
18. Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat.
Chang CC; Wang SS; Huang HC; Chan CY; Lee FY; Lin HC; Nong JY; Chuang CL; Lee SD
Eur J Pharmacol; 2011 Sep; 666(1-3):226-32. PubMed ID: 21575628
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport.
Knudsen GM; Poulsen HE; Paulson OB
J Hepatol; 1988 Apr; 6(2):187-92. PubMed ID: 3411098
[TBL] [Abstract][Full Text] [Related]
20. An anesthetized model of lethal canine galactosamine fulminant hepatic failure.
Sielaff TD; Hu MY; Rollins MD; Bloomer JR; Amiot B; Hu WS; Cerra FB
Hepatology; 1995 Mar; 21(3):796-804. PubMed ID: 7875678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
